SEC Form 4 · accession 0001214659-26-007262
Aquestive Therapeutics, Inc. · AQST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sherry Korczynski
Officer — Chief Commercial Officer
Period of report
Jun 8, 2026
Accepted (ET)
Jun 9, 2026 · 2:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001398733
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 8, 2026 | F | 2,714 | $0.00 | D | 238,403 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.